Published in PLoS One on May 13, 2010
The hallmarks of cancer. Cell (2000) 113.05
Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A (1992) 10.19
Immune surveillance of tumors. J Clin Invest (2007) 5.04
Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. Dev Cell (2004) 4.71
Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell (2006) 4.07
Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL). J Clin Oncol (2008) 2.57
Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development (1996) 2.35
Genomic alterations in tumor stroma. Cancer Res (2009) 2.18
Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies. Cancer Res (2008) 1.69
Development of a three-dimensional multiscale agent-based tumor model: simulating gene-protein interaction profiles, cell phenotypes and multicellular patterns in brain cancer. J Theor Biol (2006) 1.66
Variability and robustness in biomolecular systems. Mol Cell (2007) 1.61
Predictive oncology: a review of multidisciplinary, multiscale in silico modeling linking phenotype, morphology and growth. Neuroimage (2007) 1.39
Inhibitor of apoptosis proteins as targets for anticancer therapy. Expert Rev Anticancer Ther (2007) 1.34
Simulating the hallmarks of cancer. Artif Life (2006) 1.25
Modeling somatic evolution in tumorigenesis. PLoS Comput Biol (2006) 1.22
Mathematical models of targeted cancer therapy. Br J Cancer (2006) 1.11
Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. Clin Cancer Res (2001) 1.10
The role of apoptotic or nonapoptotic cell death in determining cellular response to anticancer treatment. Eur J Surg Oncol (2006) 0.98
Simulating invasion with cellular automata: connecting cell-scale and population-scale properties. Phys Rev E Stat Nonlin Soft Matter Phys (2007) 0.97
The migration of cells in multicell tumor spheroids. Bull Math Biol (2001) 0.96
Activated intrinsic apoptosis pathway is a key related prognostic parameter in acute myeloid leukemia. J Clin Oncol (2007) 0.89
Cancerous tumor: the high frequency of a rare event. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 0.78
Therapy-induced apoptosis in primary tumors. Adv Exp Med Biol (2007) 0.78
Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol. Neuron (2008) 3.13
Transcriptional responses to estrogen and progesterone in mammary gland identify networks regulating p53 activity. Endocrinology (2008) 0.96
Memory reconsolidation for natural language processing. Cogn Neurodyn (2009) 0.96
A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer. Oncologist (2011) 0.94
Conversion of laparoscopic cholecystectomy to open cholecystectomy in acute cholecystitis: artificial neural networks improve the prediction of conversion. World J Surg (2001) 0.80
Factors affecting rise in the incidence of infiltrating lobular carcinoma of the breast. Isr Med Assoc J (2010) 0.80
Computation in gene networks. Chaos (2004) 0.80
Cystic-appearing pleural metastasis in a patient with recurrent phyllodes tumor. Breast J (2005) 0.80
Mitomycin C and vinblastine: an active regimen in previously treated breast cancer patients. Tumori (2010) 0.79
Logical and symbolic analysis of robust biological dynamics. Curr Opin Genet Dev (2010) 0.79
The super-Turing computational power of plastic recurrent neural networks. Int J Neural Syst (2014) 0.78
Intracellular inhibitory effects of Velcade correlate with morphoproteomic expression of phosphorylated-nuclear factor-kappaB and p53 in breast cancer cell lines. Ann Clin Lab Sci (2005) 0.77
The computational power of interactive recurrent neural networks. Neural Comput (2012) 0.76
Israel-Gaza conflict. Lancet (2009) 0.75
Trends in breast cancer incidence associated with reductions in the use of hormone replacement therapy. Cancer Epidemiol (2010) 0.75
Orbital metastasis as the presenting symptom of extensive stage small cell lung cancer. Eur J Intern Med (2007) 0.75
Pamidronate resistance and associated low ras levels in breast cancer cells: a role for combinatorial therapy. Ann Clin Lab Sci (2004) 0.75
Resilience and psychosocial adjustment in digestive system cancer. J Clin Psychol Med Settings (2015) 0.75
The role of upper gastrointestinal swallow study in patients undergoing proximal or total gastrectomy. Isr Med Assoc J (2010) 0.75